| Literature DB >> 26759614 |
Gerusa C Halila1, Edson H Junior2, Michel F Otuki3, Cassyano J Correr4.
Abstract
BACKGROUND: In order to provide appropriate advice to the patient at the time of dispensing and over-the-counter (OTC) medication counseling, community pharmacists need access to current and reliable information about medicines. Brazilian pharmacists have assumed new functions such as prescribing medication, in a dependent model, based in protocols.Entities:
Keywords: Brazil; Evidence-Based Practice; Nonprescription Drugs; Pharmacies; Professional Practice
Year: 2015 PMID: 26759614 PMCID: PMC4696117 DOI: 10.18549/PharmPract.2015.04.597
Source DB: PubMed Journal: Pharm Pract (Granada) ISSN: 1885-642X
Characteristics of pharmacists in this study.
| Characteristics | n (%) |
|---|---|
| Gender | |
| Male | 163 (30.6%) |
| Female | 370 (69.4%) |
| Community pharmacy experience | |
| 1 year or less | 20 (3.7%) |
| 2 to 5 years | 164 (30.8%) |
| 6 to 10 years | 143 (26.8%) |
| 11 to 15 years | 80 (15%) |
| 16 to 20 years | 58 (10.9%) |
| > 20 years | 68 (12.8%) |
| Degrees | |
| Graduation | 265 (49.7%) |
| Professional postgraduate course | 245 (46%) |
| MSc | 20 (3.7%) |
| PhD | 3 (0.6%) |
| Type of pharmacy worked in | |
| Local pharmacy chain | 174 (32.6%) |
| State pharmacy chain | 49 (9.2%) |
| National pharmacy chain | 97 (18.2%) |
| Independent | 213 (40%) |
Important factors to consider when making decision about a nonprescription medicine to the patient
| % respondents | |
|---|---|
| Cost of product to the customer | 46.0% |
| Efficacy | 97.0% |
| My previous experience with the product | 54.8% |
| Customer’s preference | 21.2% |
| Adverse reactions | 62.3% |
| Product profit | 18.8% |
Figure 1Responses of pharmacists when asked about the sources of information in case of doubts.
*ANVISA: National Health Surveillance Agency (regulatory agency in Brazil).
*CRF/CFF: Parana Pharmacists Association / Brazilian Pharmacists Association.
Knowledge of the terms related to Evidence-Based Health (number and percentage of respondents).
| I do not know what this term means and think it would not be helpful to know it | I do not know what this term means, but I would like to | I have some understanding of this term | I have some understanding of this term and could explain it to others | |
|---|---|---|---|---|
| Randomized controlled trial | 22 (4.1%) | 172 (32.3%) | 260 (48.8%) | 79 (14.8%) |
| Systematic review | 22 (4.1%) | 207 (38.8%) | 243 (45.6%) | 61 (11.5%) |
| Meta-analysis | 30 (5.6%) | 315 (59.1%) | 145 (27.2%) | 43 (8.1%) |
| Number needed to treat | 39 (7.3%) | 343 (64.3%) | 117 (22%) | 34 (6.4%) |
| Confidence interval | 25 (4.7%) | 229 (43%) | 191 (35.8%) | 88 (16.5%) |
| Relative risk | 20 (3.8%) | 166 (31.1%) | 265 (49.7%) | 82 (15.4%) |
| Publication bias | 36 (6.8%) | 339 (63.6%) | 114 (21.4%) | 44 (8.2%) |
| Case-control study | 24 (4.5%) | 147 (27.6%) | 249 (46.7%) | 113 (21.2%) |
| Cohort study | 30 (5.6%) | 267 (50.1%) | 178 (33.4%) | 58 (10.9%) |
| p-value <0.05 | 34 (6.4%) | 302 (56.7%) | 147 (27.5%) | 50 (9.4%) |
Figure 2Comparison of participants’ responses in relation to pharmacists prescribing medications whose dispensation does not require a prescription by a physician.